In schizophrenia, neurocognition, social cognition and functional outcome are all inter-related, with social cognition mediating the impact that impaired neurocognition has on functional outcome. Less clear is the nature of the relationship between neurocognition, social cognition and functional outcome in individuals at clinical high risk (CHR) for psychosis. 137 CHR participants completed a neurocognitive test battery, a battery of social cognition tasks and the Social Functioning Scale. Confirmatory factor analysis showed that all social cognition tasks were reliable and valid measures of the latent variable. The path from neurocognition to functioning was statistically significant (standardized coefficient β = 0.22, p b 0.01). The path from social cognition to functioning was also statistically significant (β = 0.27, p b 0.05). In the mediation model the bootstrapping estimate revealed a nonsignificant indirect effect that was the association of social cognition with neurocognition and with functional outcome (β = 0.20, 95% CI = −0.07 to 0.52, p = 0.11). However, social cognition was significantly associated with neurocognition (β = 0.80, p b 0.001) and the path from neurocognition to functioning was no longer significant as soon as the mediator (social cognition) was entered into the mediation model (β = 0.02, p = 0.92). All of the model fit indices were very good. Unlike what has been observed with psychotic patients, social cognition does not seem to mediate the pathway from neurocognition to functional outcome when assessed with a measure of social attainment in individuals at CHR for psychosis.
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Introduction
It is well established that individuals with schizophrenia at all stages of the illness evidence deficits in neurocognition, social cognition, and functional outcome (Green et al., 2012; Keefe and Harvey, 2012) . In particular, poor functional outcome tends to persist even when symptoms are in remission (Tandon et al., 2010) . Thus, to ultimately achieve recovery, it is necessary to understand its key determinants and to direct rehabilitation efforts to factors that may contribute to improved functioning.
Many studies have highlighted links between neurocognition, social cognition and functional outcome at both the first episode of psychosis as well as for individuals who are experiencing a more chronic course of illness (e.g. Allott et al., 2011; Fett et al., 2011) . Using sophisticated modelling techniques, several of these studies have demonstrated a mediational role for social cognition (e.g. Addington et al., 2006b Addington et al., , 2010 Schmidt et al., 2011) . Furthermore, in these models social cognition is more proximal to outcome than is neurocognition, that is, the average amount of variance in outcome explained by social cognition is usually greater than the variance explained by neurocognition (Fett et al., 2011) . Understanding this relationship may be important for planning targeted interventions. In fact growing attention is being given to the development of new treatments specifically focused on cognitive (e.g. Wykes et al., 2011) or social cognitive training (e.g. Horan et al., 2008) with encouraging preliminary results.
Recent progress in risk identification methodology has made it possible to identify individuals who are putatively prodromal for psychosis, that is at clinical high risk (CHR) of developing psychosis (McGlashan et al., 2010) . It has been consistently reported that similar or less severe deficits in neurocognition, social cognition and functional outcome are observed in CHR individuals when compared to individuals at either their first episode or those who have a more chronic course of illness (Addington et al., 2008; Thompson et al., 2011; Addington and Barbato, 2012; Fusar-Poli et al., 2012b; Green et al., 2012) . Although deficits in neurocognition (Fusar-Poli et al., 2012b) may play a role in predicting transition to psychosis in individuals at CHR, only one study to date has demonstrated that a combination of neurocognitive tasks and social cognition assessed by a theory of mind task was related to conversion (Kim et al., 2011) . However, the associations amongst social cognition, neurocognition and functional outcome have never been assessed in CHR individuals. Examining if social cognition does mediate between neurocognition and functional outcome at this stage of risk may add to our understanding of the development of psychosis. In terms of prevention, CHR individuals represent a unique opportunity to intervene early and possibly delay or prevent illness progression. Although only about one third of individuals at CHR will develop psychosis, the remaining two thirds will most likely continue to have poor functional outcome (Addington et al., 2011) , and thus may benefit from more effective treatment intervention as well. Therefore, an improved understanding of the role of these early deficits in cognition and social cognition could be essential to intervening with respect to functional outcome.
Thus, based on the fact that a) a mediation role for social cognition has been observed at both the first episode and later stages of stages of psychosis; b) deficits in social cognition, neurocognition and functional outcome are relatively stable across phases of the illness including both the acute and remission phase; and c) CHR individuals as a group experience similar deficits in neurocognition, social cognition and functional outcome, we predict that social cognition will play a mediation role in the CHR population. The specific aim of this study is, using Structural Equation Modeling (SEM), to verify if social cognition has a mediating role between neurocognition and functioning. To our knowledge this is the first study that attempted to verify this model in CHR individuals.
Method

Sample
The sample consisted of 137 (81 males, 56 females) individuals at CHR of psychosis. All of the participants were part of a multi-site NIMH funded study called "Enhancing the Prospective Prediction of Psychosis" (PREDICT). This was a 2-year longitudinal study conducted at the University of Toronto, the University of North Carolina (UNC), and Yale University to determine predictors of conversion in individuals at CHR of developing psychosis; 57 were recruited at Toronto, 55 at UNC and 25 at Yale. All participants met the Criteria of Prodromal Syndromes (COPS) based on the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al., 2010) . One hundred and thirty-six CHR participants met attenuated positive symptom syndrome (APSS) criteria, which includes the emergence or worsening of a non-psychotic level disturbance in thought content, thought process or perceptual abnormality over the past year, and one participant met criteria for genetic risk and deterioration (GRD), which required either a first degree relative with a psychotic disorder or the subject having schizotypal personality disorder (SPD) plus at least a 30% drop in functioning on the General Assessment of Functioning (GAF) scale in the past 12 months. Participants were excluded if they met criteria for any current or lifetime axis I psychotic disorder, prior history of treatment with an antipsychotic, IQ b than 70, or past or current history of a clinically significant central nervous system disorder that may confound or contribute to clinical high risk symptoms. Participants were excluded if they were using antipsychotics at baseline. Furthermore, antipsychotics were not used at any later points in this study.
Measures
Criteria for a prodromal syndrome were determined using the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al., 2010) . Symptoms were assessed with the Scale of Prodromal Symptoms (SOPS), which consists of 19 items in 4 symptom domains: positive, negative, general, and disorganized.
Neurocognition
Neurocognitive tests were chosen on the basis of their demonstrated reliability, ability to discriminate patients with schizophrenia from healthy participants, lack of ceiling and floor effects in a CHR population, and appropriateness for individuals as young as 14 years of age. When available, age appropriate test versions were used, and raw scores were converted to age matched standard scores where appropriate. Our sample included participants younger than 14 (12-13). Therefore, we re-analyzed the data without the 12-13 year old participants and the results did not change. (CPT-IP) , and Digit Span Distractibility. These tests covered the neurocognitive domains of verbal fluency, processing speed, motor function, executive function, verbal memory, verbal and spatial working memory, and attention. This study was designed prior to the MATRICS battery but our battery is very similar with the CPT-IP and the TMT A being common to both.
Social cognition
Measures of social cognition included: the Facial Emotion Identification Test (FEIT), the Facial Emotion Discrimination Test (FEDT) (Kerr and Neale, 1993) , and Affective prosody (AP) (Edwards et al., 2001) , to assess affect processing, and the "Reading the Mind in the Eyes" task (Baron-Cohen et al., 2001 ) to assess theory of mind.
Functional outcome
Functional outcome was assessed using the Social Functioning Scale (SFS), a self-report questionnaire that has excellent psychometric properties (Birchwood et al., 1990) . The SFS has a total score and 7 sub-scores: withdrawal/social engagement, interpersonal communication, independence-performance, independence-competence, recreation, prosocial, and employment/occupation.
Procedures
All three sites involved in this longitudinal study recruited CHR individuals. Raters were experienced research clinicians who demonstrated adequate reliability at routine reliability checks. Gold standard posttraining agreement on the critical threshold for determining initial eligibility and subsequent conversion status based on the SIPS was excellent (kappa = 0.90). The PI or clinical psychiatrist or psychologist at each site conducted a comprehensive clinical assessment to determine if entry criteria were met. J. Addington chaired weekly conference calls to review criteria for all individuals admitted to the study to ensure consensus that all participant met COPS criteria. The study protocols and informed consents were reviewed and approved by the ethical review boards of all three study sites. All of the data were collected at the baseline assessment.
Data analysis
To perform the mediator analysis, a neurocognitive factor was obtained from all neurocognitive measures by using principle component factor analysis, which was deemed appropriate for the data (Bartlett test p b 0.001, Kaiser-Meyer-Olkin index = 0.83). This analysis generated 6 factors with eigenvalues greater than 1. However, the tests all loaded on one factor with most of the variance being accounted for by the first factor (36.5%), therefore only this factor was used in the mediation model. We computed two-tailed Pearson product-moment correlations to examine relationships among neurocognition, social cognition and functional outcome. We used
